BiotechBiotech Firms Secure Capital as Gene Therapy Trials Target 5 Million Global Patients with Dry AMDSalvado•Mar 26, 2026
Healthcare InnovationAI-Designed Drug Candidates Show Clinical Progress Across US and Canadian TrialsSalvado•Mar 24, 2026
Healthcare & PharmaceuticalsGene Therapy, mRNA and CRISPR: The Global Biotech Boom Reshaping How the World Finances MedicineViaNews Editorial Team•Feb 18, 2026
Biotechnology & Life SciencesThe Fragile Chain: How One Logistics Provider's 701-Trial Backlog Exposes a Global Cell Therapy BottleneckViaNews Editorial Team•Feb 18, 2026
Health & BiotechREGENXBIO's Duchenne Gene Therapy Targets 2027 Global Launch, Challenging Sarepta's Market LeadViaNews Editorial Team•Feb 18, 2026
